Use of the nonavalent HPV vaccine in individuals previously fully or partially vaccinated with bivalent or quadrivalent HPV vaccines. Issue 6 (3rd February 2016)

• Record Type: Journal Article
• Authors: Van Damme, Pierre; Bonanni, Paolo; Bosch, F. Xavier; Joura, Elmar; Krüger Kjaer, Susanne; Meijer, Chris J.L.M.; Petry, Karl-Ulrich; Soubeyrand, Benoit; Verstraeten, Thomas; Stanley, Margaret
• Is Part Of: Vaccine. Volume 34:Issue 6(2016)
• Page Start: 757
• Page End: 761
• Publication Date: 2016-02-03
• Subjects: Human papillomavirus -- Cervical cancer -- Revaccination; Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2015.12.063
• Languages: English
• ISSNs: 0264-410X

Abstract

Abstract: With the availability of the nonavalent human papillomavirus (HPV) vaccine, vaccinees, parents and healthcare providers need guidance on how to complete an immunization course started with the bi- or quadrivalent vaccine and whether to revaccinate individuals who have completed a full immunization course with the bi- or quadrivalent vaccine. To answer these questions three parameters should be considered: age at the start of vaccination (9 to 14 years of age versus 15 years and older, the cut-off for 2 or 3 doses schedule), the number of doses already received and the time interval between doses. Based on a number of scenarios, we propose that the 9-valent vaccine can be used to complete an incomplete vaccination regimen or might be added to a previous completed schedule to extend protection.